Outset Medical (NASDAQ:OM) reported quarterly losses of $(3.24) per share which missed the analyst consensus estimate of $(0.94) by 244.68 percent. This is a 62.11 percent increase over losses of $(8.55) per share from the same period last year. The company reported quarterly sales of $29.75 million which beat the analyst consensus estimate of $27.81 million by 6.98 percent. This is a 5.62 percent increase over sales of $28.17 million the same period last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。